Scientific Advisory Board

Scientific Advisory Board Tasks:

• Advice on the coherence within Lygatures’ project portfolio on an annual basis. Provide feedback and identify chances for cross-fertilization between projects in the various domains.
• Provide input on the development of new public-private initiatives from an international perspective, building upon the strengths of the Dutch Life Sciences & Health sector and taking into account the possible connects with international initiatives, such as Horizon2020, the Innovative Medicines Initiative, etc.
• On an ad hoc basis: review of project proposals that will be submitted by Lygature towards various funders of consortia (e.g. Gates Foundation, GHIT fund, etc). 

Scientific Advisory Board Members

The members of the Scientific Advisory Board together span the dimensions in which Lygature is active: scientific discipline (medtech, pharma), geographic scope (national, international), organizational nature (public, private), etc. Current members of the Scientific Advisory Board are:

• Ton Rijnders, PhD - chairperson (Former General Director Oncode Institute, former Scientific Director Lygature and TI Pharma)
• Rob Williams, PhD - (Chief Drug Development Scientist at the Centre for Drug Development, Cancer Research UK)
• Sjaak Deckers, PhD - (Co-founder and CEO of G-Therapeutics BV)
• Tomas Salmonson PhD - (Partner at Consilium Salmonson & Hemmings, former chair of the Committee for Human Medicinal Products at the European Medicines Agency)

Read more

Lygature Scientific Advisory Board: report on the fourth meeting
Lygature Scientific Advisory Board: report on the third meeting
Lygature Scientific Advisory Board: report on second meeting
Lygature installs Scientific Advisory Board: report on the first meeting